All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns
OTTAWA – Health Canada is informing Canadians that Marcan Pharmaceuticals has recalled all lots of all MAR-Diltiazem CD products in response to data integrity concerns that could lead to incorrect dosing.
Health Canada is warning Canadians about the online retailer Steroid Hub Canada because it is selling unauthorized health products that may pose serious health risks.
Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
OTTAWA – Health Canada is informing Canadians that Allergan Inc. has decided to withdraw the drug Fibristal (ulipristal acetate), used to treat uterine fibroids, from the Canadian market. Allergan made this decision in response to a number of international cases of serious liver injury requiring liver transplantation. The company determined that it is not possible to identify which patients are most at risk of developing liver injury, nor any measures that could further reduce the risk.
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. Thetable belowis updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as “poppers,” or for lightening skin or treating skin conditions (such as eczema or psoriasis). These products are labelled to contain or have been tested and found to contain dangerous ingredients. Links to previous tables with affected products are also available below.
Heath Canada Notices
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir